NasdaqGS - Nasdaq Real Time Price USD
Syndax Pharmaceuticals, Inc. (SNDX)
9.99
-0.65
(-6.11%)
At close: May 7 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 10 |
| Avg. Estimate | -0.98 | -0.9 | -3.7 | -2.5 |
| Low Estimate | -1.07 | -1.05 | -4.15 | -3.32 |
| High Estimate | -0.87 | -0.72 | -3.22 | -0.88 |
| Year Ago EPS | -0.8 | -0.98 | -3.72 | -3.7 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 11 |
| Avg. Estimate | 27.49M | 34.02M | 123.54M | 248.79M |
| Low Estimate | 17.44M | 20.47M | 83.05M | 159.82M |
| High Estimate | 34.1M | 43.6M | 154.2M | 406.48M |
| Year Ago Sales | 3.5M | 12.5M | 23.68M | 123.54M |
| Sales Growth (year/est) | 685.50% | 172.20% | 421.70% | 101.39% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.91 | -1.06 | -0.23 | -1.27 |
| EPS Actual | -0.8 | -0.98 | -1.1 | -0.98 |
| Difference | 0.11 | 0.08 | -0.87 | 0.29 |
| Surprise % | 12.17% | 7.57% | -380.58% | 23.04% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.98 | -0.9 | -3.7 | -2.5 |
| 7 Days Ago | -1 | -0.96 | -3.81 | -2.72 |
| 30 Days Ago | -0.99 | -0.95 | -3.79 | -2.75 |
| 60 Days Ago | -0.99 | -0.95 | -3.79 | -2.77 |
| 90 Days Ago | -1.06 | -1.07 | -3.86 | -2.53 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 2 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SNDX | -22.16% | 8.44% | 0.59% | 32.28% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Scotiabank: Sector Perform to Sector Perform | 5/6/2025 |
| Reiterates | Guggenheim: Buy to Buy | 5/6/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/20/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/4/2025 |
| Maintains | Citigroup: Buy to Buy | 3/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2025 |
Related Tickers
KURA Kura Oncology, Inc.
5.65
-2.50%
BPMC Blueprint Medicines Corporation
99.80
+0.65%
DAWN Day One Biopharmaceuticals, Inc.
6.30
-9.87%
TARS Tarsus Pharmaceuticals, Inc.
47.35
+1.94%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
JANX Janux Therapeutics, Inc.
25.70
+0.63%
RARE Ultragenyx Pharmaceutical Inc.
33.42
-4.68%
CYTK Cytokinetics, Incorporated
33.04
-2.74%
ARVN Arvinas, Inc.
6.67
-4.03%
APLS Apellis Pharmaceuticals, Inc.
17.99
-5.91%